Midwest technology bosses should stop flaunting their wealth at work ( king big purchases thats a bad sign in...)

Midwest technology bosses should stop flaunting their wealth at work

king big purchases, thats a bad sign in and of itself. I'm talking Enron and Tyco here.

Prudence shows itself in lots of different ways. Personal and conspicuous spending is a pretty visible one. A lot of very fast cars in the parking lot can mean that the company is going great and all of you will soon prosper (or not). Be warned.

Its all a matter of context. If your stock optio......

Full article >>>

Source:wistechnology.com By Liz Ryan 10/24/04

Page: 1 2 3 4
Related biology technology :

1. Midwest life science stocks kept sizzling in Q2
2. Midwest life science stocks sizzle in a tepid first quarter
3. A Midwest passage to India, Part II
4. Midwest offers non-stop flight to North Carolina research park
5. A Midwest life-science odyssey comes full circle
6. Midwest hotter for healthcare investments
7. A Midwest small-cap, life-science surprise package
8. 2006: A mixed blessing for Midwest life science companies
9. Midwest gaining stature in nanotech research
10. Midwest colleges strong contenders for NIH funds
11. Japan on the rebound: Implications for Midwest

Post Your Comments:

(Date:11/6/2009)...G VALLEY, Calif., Nov. 6 Calbiotec... Small Business Innovative Research (SBIR) Phase I...terial command. Under terms of the agreement, Calb...s) for the diagnosis of Dengue virus. ,, Den...sents a major threat to military forces deployed t...

(Date:11/5/2009)...ERSBURG, Md., Nov. 5 Gen...ancial results for the third quarter ended Septemb...llion ($0.04 per share) for the three months ended... million ($0.08 per share) in the comparable quart..., 2009, GenVec,s net loss was $14.1 million ($0.15...

(Date:11/5/2009)...rence Call on Thursday, November 5, 2009 at 4:30 p...Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmace...AQ: OGXI ) today reported unaudited financial res...eptember 30, 2009 and reviewed the Company,s highl...lowing consolidated results reflect the operations...

(Date:11/5/2009)...IEGO, CA, November 5, 2009 /PRNewswire-FirstCall/ ...ed on using proprietary taste receptor-based techn...he food, beverage, and ingredient supply industrie...financial results for the third quarter ended Sept...e third quarter of 2009, compared to $4.0 million ...

[0] Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus [0] GenVec Reports Third Quarter 2009 Financial Results [0] OncoGenex Reports Third Quarter 2009 Financial Results [0] SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS

...nference Call Tomorrow (Tuesday) at 8:30 am EDT to... Valley Cottage, NEW YORK, September 10 XTL,Biop...E: XTL) today announced,the initiation of a Phase ... norepinephrine reuptake inhibitor (SNRI) - for th...ine is being developed for the treatment of diabet...

...ltern, a leading global research,organization, is ...,Chiltern,s Country Manager for the Czech Republic...e year award. The award ceremony was held in,Londo...om amongst his peers by a panel of judges who,revi...ccessful conclusion,of clinical trials. The judgin...

Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings

Other Biology Technology:XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 2 XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 3 XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 4 XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 5 XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 6 XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 7 Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year 2

XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings

(Date:11/9/2009)...s inspired a 3.2m, three-year research project tha...security, energy and the environment. The Universi...QinetiQ have just signed a collaborative contract ...g physical sciences research. , Over the next t...y of Exeter and QinetiQ will work together to deve...

(Date:11/9/2009)...09 / b3c newswire / - Today, TNO, a Dutch contr...erican organization for contract research and cons... letter of intent with regard to TNOs dynamic in ...intent proposes a collaboration in which Seventh W...ion in North America. The TIM systems will be used...

(Date:11/9/2009)...leaders from around the world will gather in Bosto...ar Targets and Cancer Therapeutics International C...mation on important cancer therapies in developmen...it effectively we need a greater understanding of ...el," said Lewis Cantley, Ph.D., director of the ca...

Breaking Biology News(10 mins):£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2 TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2 Exponent to Announce Second Quarter 2009 Results 51709 1 Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 1 Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 2 Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 3 Reminders Boost Mammography Appointments 51703 1 Reminders Boost Mammography Appointments 51703 2

[0] £3.2m ($5.4 million) research project to capture brilliance of butterfly wings [0] TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services [0] AACR, NCI and EORTC to host Molecular Targets and Cancer Therapeutics International Conference

...ls have been little more than electronic versions ...the launch of PLoS ONE, which publishes primary re...pre- and post-publication peer review to maximize ...is published by the Public Library of Science (PLo...e the world,s scientific and medical literature a ...

...Many of them had narrow, pointed teeth, which were...wing them. But how did they then grind their food?... they were helped by stones which they swallowed. ...nd of ,gastric mill,. But this assumption does not...ties of Bonn and Tübingen have now proved. Their r...

... based on a combination of satellite data, compute...moke from Alaskan and Canadian forest fires as muc... away in Houston during a two-day period in July 2...in the Journal of Geophysical Research, offers sci...effects from pollutants generated thousands of mil...

Other Biology News:PLoS ONE is launched by the Public Library of Science 2 PLoS ONE is launched by the Public Library of Science 3 Dinosaurs -- stones did not help with digestion 2 Dinosaurs -- stones did not help with digestion 3 NASA study: Alaskan fires affected Houston air quality in 2004 2 NASA study: Alaskan fires affected Houston air quality in 2004 3

PLoS ONE is launched by the Public Library of Science Dinosaurs -- stones did not help with digestion NASA study: Alaskan fires affected Houston air quality in 2004

Fingerprinting II Database Sharing Tools from Bio-Rad

Fingerprinting II Identification and Library Manager from Bio-Rad

DNA Engine Opticon 2 Continuous Fluorescence Detection System from Bio-Rad

...High Quality, Functionally-Validated, Ion Channel ...ng a critical role in nerve and muscle function an...d the heart. Drugs that modulate ion channels have...europathic pain, cardiac arrhythmia, hypertension,...

Biology Products:

Fingerprinting II Database Sharing Tools from Bio-Rad Fingerprinting II Identification and Library Manager from Bio-Rad DNA Engine Opticon 2 Continuous Fluorescence Detection System from Bio-Rad hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate

( king big purchases thats a bad sign in...)Midwest technology bosses should stop flaunting their wealth at work